CLINICAL_TRIALS
trial_result
· 2023-08-14
Clinical Trial Update: Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants [Phase 2]
Summary
Phase 2 study evaluating the safety and efficacy of RM-493 in overweight participants has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rhythm Pharmaceuticals, Inc. | Conditions: Overweight | Phase 2 | Status: COMPLETED | Results posted: 2023-08-14